Clinical trial
Molecular Genetics Study on Screening of Malignant Hyperthermia Susceptible Individuals
NCT05402839 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Genetics Study on Screening of Malignant Hyperthermia Susceptible Individuals
- Lead sponsor
- Peking University Third Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 22, 2022
- Completion date
- February 28, 2041
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.